Telix Pharmaceuticals Appoints Dr. Mark Nelson as Interim Chair After Tiffany Olson Resignation
I'm PortAI, I can summarize articles.
Telix Pharmaceuticals Limited has announced the resignation of Ms. Tiffany Olson as Non-Executive Director and Board Chair, effective February 3, 2026. Dr. Mark Nelson, an independent Non-Executive Director, will serve as Interim Chair. The Board is currently in the process of appointing new Non-Executive Directors and a new Independent Chair.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments